无创通气治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭  

作　　者：李胜利[1] 

机构地区：[1]东莞市人民医院呼吸科,广东523000

出　　处：《当代医学》2013年第15期12-14,共3页Contemporary Medicine

摘　　要：目的探讨无创正压通气在慢性阻塞性肺疾病(COPD)合并II型呼吸衰竭的治疗效果。方法将60例COPD合并II型呼吸衰竭患者随机分为治疗组和对照组各30例,所有患者均给予鼻导管吸氧、抗感染、对症等常规治疗,治疗组在此基础上应用无创正压通气治疗,比较两组主要血气指标、生命体征变化、治疗效果及患者预后情况。结果治疗组有效率86.67%,明显高于对照组的66.67%,差异有统计学意义(P<0.05);治疗组的气管插管率及住院时间为13.33%、(12.3±3.5)d,明显低于对照组33.33%及(21.4±5.6)d,比较具有统计学意义(P<0.05)。结论无创正压通气治疗COPD合并II型呼吸衰竭患者疗效确切,降低了插管率及住院时间,值得临床推广应用。Objective To investigate the treatment effect of NIPPV in the treatment on chronic obstructive pulmonary disease with type Ⅱ respiratory failure. Methods 60 cases of COPD with type Ⅱ respiratory failure were randomly divided into treatment and control group, 30 cases in each group, all patients are given oxygen nasal tube, resistance to infection, such as symptomatic of conventional treatment, treatment on the basis of application of non-invasive positive pressure ventilation for treatment. Main effects on blood gas indexes, changes in vital signs, treatment effects and prognosis were compared. Results Treatment group effective rate was 86.67%, significantly higher than the control group 66.67%, the difference was statistically significant （P 〈 0.05）; Endotracheal intubation rate of the treatment group and length of hospital stay was 13.33%, （12.3±3.5 ）days, 33.33% and（ 21.4±5.6 ）days, significantly lower than the control group was statistically significant （P 〈 0.05）. Conclusion NIPPV in the treatment of COPD with type Ⅱ respiratory failure with good efficacy, reduce the rate and duration of intubation time, and clinical application.

关 键 词：无创正压通气 慢性阻塞性肺疾病 呼吸衰竭 

分 类 号：R563.9[医药卫生—呼吸系统]